Aspire Biopharma Holdings (ASBP) Gross Profit (QoQ) (2025 - 2026)

Aspire Biopharma Holdings (ASBP) Gross Profit (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn -
3 Akari Therapeutics 973.81 Bn 973.81 Bn -
4 BeOne Medicines 471.51 Bn 466.72 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.94 Bn 114.70 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.30 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.88 Bn 50.69 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Aspire Biopharma Holdings 1.09 Mn -736,215.39 5,750.00

Historic Data

Download Data
DateValue
Mar 31, 2026 675.00%
Dec 31, 2025 -213.12%